UBS maintains Buy on Teradyne, raises price target to $500
UBS analyst Timothy Arcuri maintained a Buy rating on Teradyne (NASDAQ: TER) and raised the price target to $500 from $440.

*this image is generated using AI for illustrative purposes only.
UBS analyst Timothy Arcuri has maintained a Buy rating on Teradyne (NASDAQ: TER) while raising the stock's price target to $500. The new target represents an increase from the previous level of $440.
The adjustment reflects a revised outlook on the company's valuation. Teradyne designs and develops automatic test equipment.
What specific factors drove UBS to revise Teradyne's valuation outlook?
How might Teradyne's performance be impacted by trends in the semiconductor industry?
What are the potential risks that could prevent Teradyne from reaching the new $500 price target?































